Exagen Inc.
XGN · NASDAQ
Bulios Fair Price
$4.23
49.7% downside
Trenutna cena
$8.41
Po podatkih Bulios Fair Price je delnica XGN trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Exagen Inc. (XGN) is a biotechnology company focused on developing and commercializing diagnostic tests for autoimmune diseases. Their main product is the VeraStrat test, which assists physicians in deciding on appropriate treatment for patients with lung cancer. Exagen Inc. is known for its innovative approach to developing diagnostic tools and efforts to bring improvements in the treatment of autoimmune diseases. Exagen Inc. (XGN) shares could be suitable for investors who are tracking the biotechnology sector and seeking investment opportunities in the field of autoimmune disease diagnostics and treatment.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
John Aballi
Employees
216
Headquarters
Vista
Prihajajoči dogodki
Earnings
Upcoming earnings report